| Sign In to gain access to subscriptions and/or personal tools. |
Agents that modify haemostasis after cardiopulmonary bypassUniversity of Toronto, Centre for Cardiovascular Research, The Toronto Hospital, Toronto, Ontario Reducing the whole body inflammatory response to cardiopulmonary bypass may reduce postoperative bleeding. Dipyridamole decreases platelet activation, deposition, and depletion. Antifibrinolytic agents may further reduce bleeding by reducing fibrinolysis and maintaining platelet function. This review reports the author's experience with dipyridamole and antifibrinolytic agents, membrane and bubble oxygenators, as well as the effects of warm and cold heart surgery.
Perfusion, Vol. 8, No. 1 suppl,
6-12 (1993) |
|||